{"id":"W2911614100","doi":"10.1161/circulationaha.118.035864","title":"Stroke Outcomes in the COMPASS Trial","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Boston Scientific Corporation; Eisai; Boston VA Research Institute; GlaxoSmithKline; Bayer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Daiichi Sankyo Europe; Sanofi; American Heart Association","keywords":"Medicine; Aspirin; Rivaroxaban; Stroke (engine); Internal medicine; Hazard ratio; Modified Rankin Scale; Coronary artery disease; Intracerebral hemorrhage; Warfarin; Randomized controlled trial; Anesthesia; Cardiology; Surgery; Atrial fibrillation; Confidence interval; Ischemic stroke; Subarachnoid hemorrhage","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002534537,0.00005551809,0.0001539909,0.00008006002,0.00002143492,0.00001847843,0.00004223274,0.00003495971,0.0001713093],"category_scores_gemma":[0.00005281864,0.00003597625,0.00008776244,0.0001161094,0.00000758958,0.0000724229,0.00000869965,0.00005706852,0.000218716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002897038,"about_ca_system_score_gemma":0.00001119116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001027078,"about_ca_topic_score_gemma":0.00000356291,"domain_scores_codex":[0.999386,0.00004267014,0.0001748821,0.00009550196,0.0002191377,0.00008185639],"domain_scores_gemma":[0.9996283,0.0001121081,0.00005010801,0.000179758,0.00001635757,0.00001337852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006696041,0.000007613483,0.9949416,0.000007567058,0.00001391633,9.388949e-7,0.0001227679,0.0001701931,0.0001745581,0.003005983,0.00007126093,0.0008140212],"study_design_scores_gemma":[0.01801704,0.00003505889,0.9754309,0.000005539863,0.00002562901,7.256511e-7,0.0001273485,0.001227093,0.000006567539,0.0001770678,0.004905269,0.00004172421],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851858,0.00001304152,0.0001384922,0.003898243,0.0003778083,0.00103378,6.569891e-7,0.00002497214,0.009327222],"genre_scores_gemma":[0.9984336,0.000001192255,0.00003862101,0.0003228208,0.0002606902,0.000002744531,0.00002476168,0.00000500796,0.0009104846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01951064,"threshold_uncertainty_score":0.2811225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07464536859794811,"score_gpt":0.3447212517401188,"score_spread":0.2700758831421706,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}